Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Inclusion Criteria:

• PRACTICE CRITERIA: Participating practice clusters will be required to identify one (or more) oncologist and/or advanced practice practitioner (APPs; i.e., nursepractitioners, or physician assistants) as part of study eligibility. If anotherclinician is interested in participating, please contact University of RochesterCancer Center (URCC) National Cancer Institute Community Oncology Research Program (NCORP) Research Base (RB) for approval

• Oncologists/APPs/other clinicians must be licensed to practice

• Oncologists/APPs/other clinicians must not have a plan to leave or retire fromthe NCORP practice within one year of enrolling into the study

• PRACTICE CRITERIA: Support/buy-in from oncology physicians and/or APPs and/or otherclinicians who are willing to participate in training and study procedures andenroll cancer survivors

• ENTRY CRITERIA FOR ONCOLOGY PHYSICIANS/APPS/OTHER CLINICIANS: Oncologyphysicians/APPs/other clinicians must work at a participating site with no plans toleave that practice or retire within one year of enrollment into the study. We donot require that any or all oncology physicians and/or APPs at a practice settingagree to participate. Only one clinician is required for the practice cluster to beeligible. If another clinician (other than oncology physician or APP) is interestedin participating, please contact URCC NCORP RB for approval

• CANCER SURVIVORS: 65 years or older

• CANCER SURVIVORS: Have completed or will have completed curative-intent treatment (e.g., surgery, chemotherapy, chemotherapy with radiation) for any solid tumor orlymphoma malignancy in last 6 months. If the survivor is receiving curative-intentchemotherapy, run-in study procedures can occur during the last 6 weeks ofchemotherapy.

• Cancer survivors who will receive or are receiving other treatments (e.g.,hormonal treatment, monoclonal antibodies, immunotherapy, radiation) areeligible

• For patients receiving neoadjuvant chemotherapy for curative intent, the run-inand baseline procedures can occur before or after surgery. Patients should beenrolled within 6 months from the end of surgery

• CANCER SURVIVORS: Be willing and able to come in for study visits or willing toundergo informed consent and assessments remotely via tele-health visits

• CANCER SURVIVORS: Be willing and able to provide informed consent and must signconsent in-person or remotely if it is not convenient or feasible to provideinformed consent in-person

• CANCER SURVIVORS: Speak and understand English and/or Spanish. Spanish-speakingcancer survivors are eligible as long as there are appropriate resources in placefor completion of study procedures at the practice site. Registration forSpanish-speaking cancer survivors must be approved by the URCC NCORP Research Baseafter a phone call to determine the feasibility for the practice to enroll aSpanish-speaking participant

• CAREGIVERS: 18 years or older

• CAREGIVERS: Selected by the cancer survivor when asked if there is a "family member,partner, friend or caregiver (age 18 years or older) with whom you discuss or whocan be helpful in health-related matters." A caregiver need not be someone who liveswith the cancer survivor or provides direct hands-on care

• CAREGIVERS: Speak and understand English and/or Spanish. Spanish-speaking caregiversare eligible as long as there are appropriate resources in place for completion ofstudy procedures. Registration for Spanish-speaking caregivers must be approved bythe URCC NCORP Research Base after a phone call to determine the feasibility for thepractice to enroll a Spanish-speaking participant

Exclusion Criteria:

• CANCER SURVIVORS: Have a condition that precludes their ability to participate ininformed consent or procedures (e.g., dementia)

• CAREGIVERS: Caregivers unable to understand the informed consent form or studyprocedures due to cognitive, health, or sensory impairment will be excluded

• Capacity to conduct informed consent procedures and study procedures will bedetermined by the coordinators in collaboration with the cancer survivors'oncologists. These procedures are similar to that of URCC 13070, which enrolledcaregivers of older patients with advanced cancer